Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Catheter Precision (NYSE: VTAK) posts 2025 loss, revenue up 95% and buys Flyte aviation unit
Catheter Precision (NYSE: VTAK) reported a 95% revenue increase in 2025, reaching $819 thousand, but posted a GAAP net loss of $17.7 million. Despite the growth, the company highlights significant liquidity risks, stating it needs additional financing to fund operations through fiscal year 2026. VTAK has also strategically diversified by acquiring Flyte, a regional air mobility company, creating two distinct operating platforms in medical devices and aviation.